Oncology/Hematology
Lymphoma
More in Lymphoma
Experts talk about long-term data and the importance of infection prophylaxis
Alarming mental health challenges among young cancer survivors, especially males, demand action
Benefit seen in all prespecified subgroups, including high-risk patients
New standard of care for patients in first remission?
Two-thirds of phase II patients had a complete response at 12 weeks of treatment
Nearly half of women with unusual or nonreportable cfDNA-sequencing results had cancer
Benefit shown in trial of patients flagged for high risk of cardiotoxicity
Health news and commentary gathered by MedPage Today staff
Improvements seen in pain, neuropathy, and cognitive function
May become "treatment of choice" over brentuximab vedotin for all disease stages
Likelihood of severe maternal morbidity more than 20 times higher versus the general population
News, features, and commentary about cancer-related issues
Regimen tops best historical response rate with chemoimmunotherapy in this setting
Incidence almost identical to that with standard cancer treatment in randomized trials
